
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
This week on PharmTech.com, accountability was discussed in a variety of ways. From AI systems, supply chains, and CMC decision-making, pharma is being pushed to prove it can catch its own mistakes before patients pay for them. This week’s stories show an industry trying to build correction loops into everything from algorithms to API sourcing.
In news this week, the FDA's approval of AbbVie's JUVMO (tavapadon) gives Parkinson's patients
Merck's SVP
Autumn Conference Coverage
In conference news,
In his upcoming CPHI Milan panel presentation, USP's
PharmTech also interviewed, CPHI Milan keynote speaker, USP CEO
And Azurity Pharmaceuticals CEO
Ahead of her AAPS PharmSci 360 panel, BMS's
A continued look at AI
In PharmTech’s continued coverage of AI in pharma, columnist
On an installment of the AI Pulse Check series, Open Biopharma's
On Manufacturing Intelligence,
Taken together, this week's stories make the point that trust isn't earned by getting it right once, it's earned by building the systems that catch you when you don't.
Related to this article








